Literature DB >> 17855498

Transport of a fluorescent cAMP analog in teleost proximal tubules.

Valeska Reichel1, Rosalinde Masereeuw, Jeroen J M W van den Heuvel, David S Miller, Gert Fricker.   

Abstract

Previous studies have shown that killifish (Fundulus heteroclitus) renal proximal tubules express a luminal membrane transporter that is functionally and immunologically analogous to the mammalian multidrug resistance-associated protein isoform 2 (Mrp2, ABCC2). Here we used confocal microscopy to investigate in killifish tubules the transport of a fluorescent cAMP analog (fluo-cAMP), a putative substrate for Mrp2 and Mrp4 (ABCC4). Steady-state luminal accumulation of fluo-cAMP was concentrative, specific, and metabolism-dependent, but not reduced by high K+ medium or ouabain. Transport was not affected by p-aminohippurate (organic anion transporter inhibitor) or p-glycoprotein inhibitor (PSC833), but cell-to-lumen transport was reduced in a concentration-dependent manner by Mrp inhibitor MK571, leukotriene C4 (LTC4), azidothymidine (AZT), cAMP, and adefovir; the latter two compounds are Mrp4 substrates. Although MK571 and LTC4 reduced transport of the Mrp2 substrate fluorescein-methotrexate (FL-MTX), neither cAMP, adefovir, nor AZT affected FL-MTX transport. Fluo-cAMP transport was not reduced when tubules were exposed to endothelin-1, Na nitroprusside (an nitric oxide generator) or phorbol ester (PKC activator), all of which signal substantial reductions in cell-to-lumen FL-MTX transport. Fluo-cAMP transport was reduced by forskolin, and this reduction was blocked by the PKA inhibitor H-89. Finally, in membrane vesicles from Spodoptera frugiperda (Sf9) cells containing human MRP4, ATP-dependent and specific uptake of fluo-cAMP could be demonstrated. Thus, based on inhibitor specificity and regulatory signaling, cell-to-lumen transport of fluo-cAMP in killifish renal tubules is mediated by a transporter distinct from Mrp2, presumably a teleost form of Mrp4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855498     DOI: 10.1152/ajpregu.00029.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

1.  Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.

Authors:  Dallas Bednarczyk
Journal:  Anal Biochem       Date:  2010-06-09       Impact factor: 3.365

2.  Sphingolipid signaling reduces basal P-glycoprotein activity in renal proximal tubule.

Authors:  David S Miller
Journal:  J Pharmacol Exp Ther       Date:  2014-01-02       Impact factor: 4.030

3.  Gender-specific expression of ATP-binding cassette (Abc) transporters and cytoprotective genes in mouse choroid plexus.

Authors:  Katiria Flores; José E Manautou; J Larry Renfro
Journal:  Toxicology       Date:  2017-06-03       Impact factor: 4.221

Review 4.  Assessing the bioaccumulation potential of ionizable organic compounds: Current knowledge and research priorities.

Authors:  James M Armitage; Russell J Erickson; Till Luckenbach; Carla A Ng; Ryan S Prosser; Jon A Arnot; Kristin Schirmer; John W Nichols
Journal:  Environ Toxicol Chem       Date:  2016-12-19       Impact factor: 3.742

5.  Characterization of efflux transport proteins of the human choroid plexus papilloma cell line HIBCPP, a functional in vitro model of the blood-cerebrospinal fluid barrier.

Authors:  Alexandra Bernd; Melanie Ott; Hiroshi Ishikawa; Horst Schroten; Christian Schwerk; Gert Fricker
Journal:  Pharm Res       Date:  2015-05-19       Impact factor: 4.200

6.  Zebrafish (Danio rerio) larva as an in vivo vertebrate model to study renal function.

Authors:  Jan Stephan Bolten; Anna Pratsinis; Claudio Luca Alter; Gert Fricker; Jörg Huwyler
Journal:  Am J Physiol Renal Physiol       Date:  2022-01-17

7.  Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4.

Authors:  David Hardy; Roslyn M Bill; Anass Jawhari; Alice J Rothnie
Journal:  SLAS Discov       Date:  2019-08-05       Impact factor: 3.341

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.